MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Ivenix taps ex-GI Dynamics chief Randle for CEO | Personnel Moves

Ivenix taps ex-GI Dynamics chief Randle for CEO | Personnel Moves

By

MassDevice.com Personnel MovesIvenix said in named former GI Dynamics (ASX:GID) chief Stuart Randle to be its new CEO.

Randle departed GI Dynamics in August 2014, after 10 years with the bariatric device maker. Amesbury, Mass.-based Ivenix, which raised $42 million last September, is developing an infusion management system for hospitals that will combine an information technology interface along with an adaptive fluid delivery platform.

“Over the last few years, the world-class development team at Ivenix has worked closely with nurses and other key stakeholders to take a patient-centric approach to reimagining an entire infusion management platform that we believe will result in better outcomes at a lower cost,” Randle said in prepared remarks. “With the recent successful financing, the company is poised to transform infusion therapy with its innovative, fully integrated infusion management system. I could not be more excited to join Ivenix at this time as we drive toward regulatory clearance and commercialization.”

“We are delighted to welcome Stu with his extensive global commercialization experience to the Ivenix team,” added chairman Dr. Ketan Patel, a partner at F-Prime Capital Partners, the venture capital arm of Fidelity Investments. “The Ivenix infusion management dystem combines state-of-the-art information technology with simplicity and safety. In a cost-effective and clinically meaningful way, Ivenix is transforming the infusion system from being ‘smart’ to being truly intelligent. Stu brings critical operational and commercial leadership experience at this important juncture in the company’s evolution from a development-stage to a pre-commercial stage company this year.”

 Sunshine Heart names interim CEO, clinical affairs veep
Sunshine Heart said CEO David Rosa stepped down after 6 years at the helm of the Eden Prairie, Minn.-based company, replaced on an interim basis by chairman John Erb. Sunshine Heart also said it tapped former CVRx research & innovation VP Eric Lovett to be its vice president of clinical affairs.
Read more

 Nativis names Rivera CEO
Nativis, which is developing cancer treatments using radio-frequency energy, named Chris Rivera to be its new CEO.
Read more

 EnteroMedics builds out the executive suit
EnteroMedics (NSDQ:ETRM) said it hired a trio of new executives and promoted another, naming former Pantheon Spine CEO Paul Hickey as its marketing & reimbursement SVP; medtech veteran Nick Ansari as sales SVP; Peter Delange as operations & business development SVP; and promoting CFO/COO Greg Lea to CFO/chief compliance officer. The move means that former chief commercial officer Brad Hancock, the former Flowonix Medical sales veep EnteroMedics brought on last year, will step down.
Read more

 Law firm lures 26-year FDA vet Ray
A Washington, D.C.-based law firm, O’Melveny & Myers, said it hired former FDA attorney Seth Ray, who spent 26 years at the federal safety watchdog.
Read more

 Conventus Orthopaedics names medtech vet Flora to board
Conventus Orthopaedics said it named former OmniGuide Surgical president & CEO Scott Flora, a medtech veteran who’s put in time at Covidien and Smith & Nephew (NYSE:SNN), to its board of directors.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]